No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”

Detalles Bibliográficos
Autores principales: Lebeaux, David, Revest, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332914/
https://www.ncbi.nlm.nih.gov/pubmed/32629139
http://dx.doi.org/10.1016/j.tmaid.2020.101819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332914/
https://www.ncbi.nlm.nih.gov/pubmed/32629139
http://dx.doi.org/10.1016/j.tmaid.2020.101819

Ejemplares similares